U.S. markets open in 2 hours 15 minutes
  • S&P Futures

    +14.25 (+0.31%)
  • Dow Futures

    +91.00 (+0.26%)
  • Nasdaq Futures

    +86.25 (+0.55%)
  • Russell 2000 Futures

    +6.10 (+0.27%)
  • Crude Oil

    -1.22 (-1.48%)
  • Gold

    +2.50 (+0.14%)
  • Silver

    -0.05 (-0.19%)

    +0.0005 (+0.05%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +0.60 (+3.75%)

    +0.0015 (+0.11%)

    -0.2200 (-0.19%)

    +1,791.52 (+3.03%)
  • CMC Crypto 200

    -6.78 (-0.46%)
  • FTSE 100

    -20.12 (-0.28%)
  • Nikkei 225

    -278.15 (-0.96%)

Sundial Growers Inc. (SNDL) Stock Sinks As Market Gains: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Sundial Growers Inc. (SNDL) closed the most recent trading day at $0.80, moving -1.88% from the previous trading session. This change lagged the S&P 500's daily gain of 0.17%.

Prior to today's trading, shares of the company had lost 8.17% over the past month. This has lagged the Medical sector's gain of 2.04% and the S&P 500's gain of 1.84% in that time.

Wall Street will be looking for positivity from SNDL as it approaches its next earnings report date. This is expected to be August 12, 2021. Our most recent consensus estimate is calling for quarterly revenue of $8 million, down 45.09% from the year-ago period.

SNDL's full-year Zacks Consensus Estimates are calling for earnings of -$0.08 per share and revenue of $65 million. These results would represent year-over-year changes of +69.23% and +24.93%, respectively.

Any recent changes to analyst estimates for SNDL should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 366.67% lower. SNDL currently has a Zacks Rank of #4 (Sell).

The Medical - Drugs industry is part of the Medical sector. This group has a Zacks Industry Rank of 196, putting it in the bottom 23% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow SNDL in the coming trading sessions, be sure to utilize Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sundial Growers Inc. (SNDL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research